BioCentury
ARTICLE | Company News

ILiAD Biotechnologies, Institut National de la Sante et de la Recherche Medicale, Institut Pasteur, National University of Ireland, National University of Singa

January 27, 2014 8:00 AM UTC

ILiAD, INSERM's Inserm Transfert S.A. subsidiary and Institut Pasteur partnered to optimize and develop live attenuated Bordetella pertussis vaccine technology, including the BPZE1 vaccine. A Phase I...